Markets
Hims & Hers Health CEO Andrew Dudum
Hims & Hers CEO Andrew Dudum (Business Wire)

Hims & Hers CEO sells stock after menopause expansion announcement

Hims rose more than 15% on Wednesday after the company announced it would expand its offerings, before giving back some of those gains on Thursday.

J. Edward Moreno

Hims & Hers CEO Andrew Dudum sold about $11 million in the company’s stock on Thursday, a day after the company’s announcement that it’s expanding into menopause and perimenopause treatments sent the company’s shares to an over two-month high.

Dudum sold 175,661 shares of the company on Thursday for about $62 a share, according to a regulatory filing. The sale was part of a pre-scheduled plan adopted in August 2024.

Hims rose more than 15% on Wednesday after the company’s announcement before giving back some of those gains on Thursday. Bullish retail investors speculated on Wednesday that the heavily shorted stock was undergoing a short squeeze. Dudum entertained the chatter, quoting one X post with a “👀” emoji.

In August, Dudum’s family trust sold 666,000 shares for about $50 each, making $33.5 million, marking the largest open-market insider sale of Hims stock since the company went public in 2021. (Dudum also riled up retail investors on X the day before that sale.)

A spokesperson for Hims did not immediately respond to a request for comment.

Hims stock has been volatile this year. The company has focused on growing its offerings, primarily through expanding into hormone treatments, now that its ability to sell copies of Novo Nordisk’s blockbuster weight-loss shot has become limited after the shortage of name-brand doses eased.

More Markets

See all Markets
Netflix's Upfront 2025

Netflix sinks on lower-than-expected earnings forecast

Netflix’s report dropped on the same day it officially went all-cash in its bid for Warner Bros. Discovery.

markets

United Airlines rallies after Q4 earnings and Q1 profit guidance top estimates

Shares of United Airlines are rising after the bell on Tuesday, following the release of the carrier’s fourth-quarter and full-year earnings report.

United posted adjusted earnings per share of $3.10 in Q4, above the $2.92 per share expected by Wall Street analysts polled by Bloomberg. Sales of $15.4 billion were roughly in line with the consensus estimate.

The airline also:

  • Forecast full-year earnings per share between $12 and $14, bracketing Wall Street’s call for $13.04. For Q1, management sees EPS between $1.00 and $1.50, the midpoint of which is above the $1.16 expected by Wall Street.

  • Booked $13.93 billion in passenger revenue on the quarter, up nearly 5% year over year.

“Strong revenue momentum has continued into 2026,” according the company’s press release. “The week ending January 4th was the highest flown revenue week in United history, and the week ending January 11th was the highest ticketing week and the highest week for business sales in United history.”

UAL’s premium ticket revenue climbed 9% compared to a 7% increase in basic economy revenue. The “K-shaped economy” has become increasingly visible in travel trends at major US airlines. Last week, Delta’s revenue from first-class and business passengers eclipsed its main cabin revenue for the first time.

President Trump Delivers An Announcement From The Oval Office

Pharma largely unfazed as Greenland tariffs roil markets

Drugmakers, which have spent the past six months reaching tariff deals with Trump, seem to expect some immunity from a new batch of tariffs on European countries.

markets

POET Technologies nears multiyear high on strong call demand after flagship product wins award

POET Technologies is surging on heavy volumes and high call demand after announcing that it won a Product Innovation Award at China’s Infostone awards.

The honor went to the optical communications company’s flagship product, the Teralight, which uses light to move data between chips.

“Unveiled less than a year ago at the 2025 OFC Conference, POET Teralight has driven commercial interest in the Company because of its highly integrated design and complete optical system-on-chip architecture that simplifies module development,” per the press release.

This award may be the latest excuse to buy the stock, which is up over 40% year to date.

Call activity is elevated, with nearly 37,000 having changed hands as of 10:55 a.m. ET, well above the 20-day average of 28,030 for a full session. Shares are approaching their multi-year high of $9.41.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.